Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Saltz

Showing results (51-60 of 167) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruptionAlon Scope, Anna Liza C Agero, Stephen W Dusza, et al.
Diseases of the Colon and Rectum|May 28, 2004
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapyRobert P Akbari, Philip B Paty, Jose G Guillem, et al.
British Journal of Cancer|November 30, 2018
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancerFotios Loupakis, Herbert I Hurwitz, Leonard Saltz, et al.
JCO Oncology Practice|June 24, 2020
Reply to S. Boutayeb et alEmil Lou, Muhammad Shaalan Beg, Emily Bergsland, et al.
Annals of Surgical Oncology|November 5, 2004
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcomeHarvey G Moore, Jinru Shia, David S Klimstra, et al.
Diseases of the Colon and Rectum|March 3, 2004
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resectionHarvey G Moore, Alicia E Gittleman, Bruce D Minsky, et al.
Journal of the American College of Surgeons|June 26, 2004
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancerJose G Guillem, Harvey G Moore, Timothy Akhurst, et al.
Journal of the American College of Surgeons|June 1, 2005
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty serviceDavid B Chessin, Warren Enker, Alfred M Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 28, 2009
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancerBarbara Burtness, Milan Anadkat, Surendra Basti, et al.
Clinical Trials (London, England)|October 1, 2020
Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trialsGuilherme S Lopes, Christophe Tournigand, Curtis L Olswold, et al.
Pageof 17

Showing results (51-60 of 167) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruptionAlon Scope, Anna Liza C Agero, Stephen W Dusza, et al.
Diseases of the Colon and Rectum|May 28, 2004
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapyRobert P Akbari, Philip B Paty, Jose G Guillem, et al.
British Journal of Cancer|November 30, 2018
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancerFotios Loupakis, Herbert I Hurwitz, Leonard Saltz, et al.
JCO Oncology Practice|June 24, 2020
Reply to S. Boutayeb et alEmil Lou, Muhammad Shaalan Beg, Emily Bergsland, et al.
Annals of Surgical Oncology|November 5, 2004
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcomeHarvey G Moore, Jinru Shia, David S Klimstra, et al.
Diseases of the Colon and Rectum|March 3, 2004
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resectionHarvey G Moore, Alicia E Gittleman, Bruce D Minsky, et al.
Journal of the American College of Surgeons|June 26, 2004
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancerJose G Guillem, Harvey G Moore, Timothy Akhurst, et al.
Journal of the American College of Surgeons|June 1, 2005
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty serviceDavid B Chessin, Warren Enker, Alfred M Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 28, 2009
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancerBarbara Burtness, Milan Anadkat, Surendra Basti, et al.
Clinical Trials (London, England)|October 1, 2020
Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trialsGuilherme S Lopes, Christophe Tournigand, Curtis L Olswold, et al.
Pageof 17